Related Experiment Video
Updated: Jul 19, 2026
05:58
Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
Published on: March 22, 2022
[Red blood cell antibody screening: error analysis in a french interlaboratory comparison program survey]
A Guyard1, S Albarède, L Mannessier
1Agence française de sécurité sanitaire des produits de santé, 143-147, boulevard Anatole-France, 93285 Saint-Denis cedex, France. anne.guyard@afssaps.sante.fr
Summary
In 2005, French immuno-haematology quality control found 0.64% of labs incorrectly screened for anti-KEL 1 antibodies. This study details laboratory responses and explains failures in antibody screening tests.
Area of Science:
- Immunohematology
- Clinical Laboratory Science
- Quality Control in Healthcare
Context:
- French Health Products Safety Agency oversees quality control.
- 2005 immuno-hematology testing control focused on anti-KEL 1 antibody screening.
Purpose:
- To analyze the reasons behind incorrect "negative screening" results in anti-KEL 1 antibody tests.
- To understand laboratory failures in immuno-hematology quality control.
Summary:
- 17 out of 2639 laboratories (0.64%) reported a negative screening for anti-KEL 1 antibody.
- A questionnaire was distributed to all laboratories to investigate the screening failures.
- Detailed laboratory responses and explanations for failures are presented.
Impact:
- Highlights areas for improvement in immuno-hematology testing protocols.
- Aids in refining quality control measures to prevent future screening errors.
- Contributes to enhancing patient safety through accurate blood testing.
